elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50133239-4170DB9B-CD36-4539-9FC6-F3B078E1E5E5
Q50133239-4170DB9B-CD36-4539-9FC6-F3B078E1E5E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50133239-4170DB9B-CD36-4539-9FC6-F3B078E1E5E5
MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.
P2860
Q50133239-4170DB9B-CD36-4539-9FC6-F3B078E1E5E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50133239-4170DB9B-CD36-4539-9FC6-F3B078E1E5E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd39f111193fb96450e6d09a5b2023f4706d720d
P2860
Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.